Transform your mental well-being with EXOMIND, a groundbreaking neuroscience and neuroregenerative treatment new to the United States. As the first in Oakland County, Michigan, Cutler Integrative Medicine proudly introduces this FDA-cleared therapy powered by ExoTMS technology. EXOMIND rebuilds and strengthens your brain’s natural pathways, delivering relief from depression, anxiety, and more — plus improved emotional balance and cognitive function.
Ready to feel like yourself again?
EXOMIND, developed by BTL Industries, is an advanced, non-invasive brain stimulation device that uses ExoTMS (Exosomal Transcranial Magnetic Stimulation) technology. This cutting-edge approach targets key brain regions—like the left dorsolateral prefrontal cortex (DLPFC)—to enhance neuroplasticity (your brain’s ability to form new connections) and improve communication between neurons.
Uses magnetic fields to gently stimulate nerve cells in your brain.
Improves symptoms of depression, anxiety, and other mental health conditions.
Offers high success rates — even for those who haven’t found relief with medications.
Proudly FDA-cleared for major depressive disorder (MDD) in adults who haven’t responded to antidepressants, EXOMIND is also approved by Health Canada and the European Union for treating anxiety, obsessive-compulsive disorder (OCD), and excessive eating disorders.
Your brain is a network of 100 billion neurons, connected by thousands of synapses that communicate through tiny electrical signals. EXOMIND taps into this system with Transcranial Magnetic Stimulation (TMS), using a coil that creates a magnetic field to induce gentle electric currents in your brain. This process, called long-term potentiation (LTP), boosts synaptic plasticity and releases Brain-Derived Neurotrophic Factor (BDNF) to strengthen neural resilience — especially in areas weakened by depression or stress.
helping your brain form new, healthy connections.
helping your brain form new, healthy connections.
helping your brain form new, healthy connections.
The left dorsolateral prefrontal cortex (DLPFC) is your brain’s executive control hub, managing emotions, decisions, and actions. This area can become underactive in today’s fast-paced world, even in healthy people. EXOMIND reactivates the DLPFC, restoring the balance between logic, emotion, and action for clearer thinking and greater calm.
By stimulating neurons, EXOMIND helps them connect more effectively, enhancing your brain’s natural ability to heal and adapt.
EXOMIND doesn’t just mask symptoms — it transforms how your brain works.
Here’s what it offers:
Better manage your reactions in tough situations — 90% of patients report improved regulation (2025 study of 1,200 patients).
Sharper decision-making and clearer thinking—perfect for busy lives.
Greater power over impulses and focus—85% satisfaction in willpower studies.
Enhanced attention, memory, and performance—unlocking your brain’s potential.
improvement for treatment-resistant depression (TRD) patients unresponsive to meds.
adherence rate—far higher than oral antidepressants (50-60%).
Plus, 90% of real-world users say it improves emotional regulation with minimal disruption to daily life, and it’s effective for anxiety (GAD-7 scores) and OCD behaviors too.
EXOMIND is FDA-cleared and backed by rigorous trials showing no
serious adverse events. Common side effects are mild:
Not suitable for those with intracranial implants (e.g., cochlear implants) or seizure disorders. We conduct mandatory pre-treatment screenings to ensure your safety.
Trials are exploring uses for PTSD, ADHD, and chronic pain.
Future AI-driven personalization may tailor treatments via real-time EEG feedback.
Preclinical studies suggest it could delay Alzheimer’s by boosting synaptic density— human trials are coming.
Serving Birmingham, West Bloomfield, Troy, Oakland County, and the greater Detroit area.
© 2021 Cutler Integrative Medicine. All Rights Reserved.
Website powered by: www.modrndigital.io
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (248) 663-0165